InsidersTradesSigma
Explore the complete record of transactions filed by CLAUSEN PETER, Chief Operating Officer. Officer active across 1 companies, notably Nuo Therapeutics, Inc.. Aggregated, 1 reports have been published. The latest transaction was disclosed on 29 April 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Peter Clausen is the Chief Scientific Officer and Chief Operating Officer at Nuo Therapeutics, Inc. He is responsible for the strategic direction of operations and research and development. His expertise is essential for ensuring innovation and efficiency within the company.